These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9138599

  • 41. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.
    Zupi G, Molinari A, D'Agnano I, Meschini S, Del Bufalo D, Matarrese P, Candiloro A, Calcabrini A, Citro G, Arancia G.
    Anticancer Res; 1995; 15(6B):2469-77. PubMed ID: 8669810
    [Abstract] [Full Text] [Related]

  • 42. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
    Johnston PG, Geoffrey F, Drake J, Voeller D, Grem JL, Allegra CJ.
    Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
    [Abstract] [Full Text] [Related]

  • 43. Novel vitamin D3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo.
    Koshizuka K, Koike M, Kubota T, Said J, Binderup L, Koeffler HP.
    Int J Oncol; 1998 Sep; 13(3):421-8. PubMed ID: 9683773
    [Abstract] [Full Text] [Related]

  • 44. Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine.
    Prabhakara S, Kalia VK.
    Indian J Med Res; 2008 Aug; 128(2):140-8. PubMed ID: 19001677
    [Abstract] [Full Text] [Related]

  • 45. Carrier-free prodrug nanoparticles based on lonidamine and cisplatin for synergistic treatment of breast cancer.
    Yang L, Li J, Guan Z, Zhang J, Wang X, Tang R.
    J Biomater Appl; 2022 Oct; 37(4):634-645. PubMed ID: 35689328
    [Abstract] [Full Text] [Related]

  • 46. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K, Ohno H, Nomura K, Okabe M, Kobayashi K, Niitani H.
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [Abstract] [Full Text] [Related]

  • 47. In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines.
    Kano Y, Akutsu M, Tsunoda S, Suzuki K, Yazawa Y.
    Cancer Chemother Pharmacol; 1996 May; 37(6):525-30. PubMed ID: 8612305
    [Abstract] [Full Text] [Related]

  • 48. Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cells.
    Angioli R, Janicek M, Sevin B, Estape R, Averette H, Koechli O, Untch M, Penalver M.
    Int J Oncol; 1997 Oct; 11(4):777-80. PubMed ID: 21528274
    [Abstract] [Full Text] [Related]

  • 49. Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.
    Agata N, Mase T, Izumi H, Hirano S, Iguchi H, Tone H, Takeuchi T.
    Cancer Biochem Biophys; 1995 Nov; 15(2):95-101. PubMed ID: 8590441
    [Abstract] [Full Text] [Related]

  • 50. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K, Nelson DS, Putt ME, Leeper DB, Garman B, Nathanson KL, Glickson JD.
    PLoS One; 2016 Nov; 11(6):e0157125. PubMed ID: 27285585
    [Abstract] [Full Text] [Related]

  • 51. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G, Gebbia V, Galetta D, Riccardi F, Cariello S, Gebbia N.
    Br J Cancer; 1997 Nov; 76(11):1509-17. PubMed ID: 9400950
    [Abstract] [Full Text] [Related]

  • 52. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine.
    Malorni W, Meschini S, Matarrese P, Arancia G.
    Anticancer Res; 1992 Nov; 12(6B):2037-45. PubMed ID: 1295447
    [Abstract] [Full Text] [Related]

  • 53. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J, Teicher BA, Herman TS, Holden SA, Dezube B, Frei E.
    Int J Cancer; 1991 Jun 19; 48(4):631-7. PubMed ID: 2045206
    [Abstract] [Full Text] [Related]

  • 54. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE, Korbut TT, Dupuis NP, Holden SA, Teicher BA.
    Cancer Chemother Pharmacol; 1995 Jun 19; 36(5):431-8. PubMed ID: 7634385
    [Abstract] [Full Text] [Related]

  • 55. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F.
    Drugs Today (Barc); 2003 Mar 19; 39(3):157-74. PubMed ID: 12730701
    [Abstract] [Full Text] [Related]

  • 56. [Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].
    Yamada Y, Saito H, Oie S, Takechi T, Nakano K, Takeda S.
    Gan To Kagaku Ryoho; 1990 Jul 19; 17(7):1327-31. PubMed ID: 2114827
    [Abstract] [Full Text] [Related]

  • 57. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N, Mazani M, Abbasi A, Farassati F, Amani M.
    Biomed Pharmacother; 2015 Aug 19; 74():243-51. PubMed ID: 26349992
    [Abstract] [Full Text] [Related]

  • 58. Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.
    Rowinsky EK, Kaufmann SH, Baker SD, Grochow LB, Chen TL, Peereboom D, Bowling MK, Sartorius SE, Ettinger DS, Forastiere AA, Donehower RC.
    J Clin Oncol; 1996 Dec 19; 14(12):3074-84. PubMed ID: 8955652
    [Abstract] [Full Text] [Related]

  • 59. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS, El-Demerdash E, Abdel-Naim AB, Youssef E, El-Sharkawy N, Osman AM.
    Biochem Pharmacol; 2005 Sep 01; 70(5):725-32. PubMed ID: 16005435
    [Abstract] [Full Text] [Related]

  • 60. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
    Cemazar M, Auersperg M, Scancar J, Kirbis IS, Pogacnik A, Sersa G.
    J Pharmacol Exp Ther; 2002 Jul 01; 302(1):337-43. PubMed ID: 12065735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.